Clinical features and prognoses of patients with POEMS syndrome
| Patient No | Age and sex | Duration before treatment (months) | Bone lesion | Clinical disability1-150 | Survival time (months) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Before treatment | Best during course | At the end of follow up | |||||||||
| Treated long term with melphalan and prednisolone: | |||||||||||
| 1 | 61M | 5 | None | 4 | 2 | 2 | > 44 | ||||
| 2 | 40F | 12 | Solitary | 4 | 3 | 3 | > 55 | ||||
| 3 | 47F | 5 | Solitary | 2 | 1 | 1 | > 49 | ||||
| 4 | 50M | 10 | Solitary | 2 | 1 | 1 | > 64 | ||||
| 5 | 32F | 16 | None | 2 | 1 | 1 | > 29 | ||||
| 6 | 62F | 15 | None | 4 | 3 | 6 | 50 | ||||
| Mean (SD) | 10.5 (4.3) | 3.0 (1.0) | 1.8 (0.9) | 2.3 (1.8) | |||||||
| Treated without long term chemotherapy: | |||||||||||
| 7 | 44M | 5 | None | 3 | 3 | 6 | 9 | ||||
| 8 | 63M | 7 | None | 4 | 3 | 6 | 17 | ||||
| 9 | 60M | 9 | Solitary | 4 | 4 | 6 | 11 | ||||
| 10 | 56M | 12 | Multiple | 4 | 4 | 6 | 15 | ||||
| 11 | 69M | 11 | None | 4 | 4 | 6 | 61 | ||||
| 12 | 69M | 12 | Solitary | 2 | 2 | 3 | > 74 | ||||
| Mean (SD) | 9.3 (2.6) | 3.5 (0.8) | 3.3 (0.7) | 5.5 (1.1) | |||||||
↵1-150 On the functional grading scale16; MP = melphalan-prednisolone; CP = cyclophosphamide; P = prednisolone.